Company Filing History:
Years Active: 2022
Title: Bart Cannegieter: Innovator in Intraocular Lens Design
Introduction
Bart Cannegieter is a notable inventor based in Groningen, Netherlands. He has made significant contributions to the field of ophthalmology, particularly in the design of intraocular lenses (IOLs). His innovative work aims to improve patient outcomes by reducing the risk of posterior capsule opacification (PCO).
Latest Patents
Cannegieter holds a patent for "Intraocular lenses for reducing the risk of posterior capsule opacification." This patent describes a design that increases pressure at the posterior capsular bend, which can be achieved through features such as a sharper edge design, an enlarged optical zone, and an increased vault height. The ophthalmic lens includes an optic with an anterior surface, a posterior surface, and an edge that forms an angle of less than about 90 degrees. This design is intended to enhance the performance of IOLs in preventing PCO.
Career Highlights
Bart Cannegieter is associated with Amo Groningen B.V., where he continues to develop innovative solutions in the field of eye care. His work has been instrumental in advancing the technology behind intraocular lenses, contributing to better surgical outcomes for patients.
Collaborations
Cannegieter collaborates with talented professionals in his field, including Robert Rosen and Hendrik Albert Weeber. These partnerships enhance the research and development efforts at Amo Groningen B.V., fostering a collaborative environment for innovation.
Conclusion
Bart Cannegieter's contributions to the design of intraocular lenses demonstrate his commitment to improving patient care in ophthalmology. His innovative patent reflects a significant advancement in the field, showcasing the importance of research and development in medical technology.